The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator

被引:36
|
作者
Schreiner, SA [1 ]
García-Cuéllar, MP [1 ]
Fey, GH [1 ]
Slany, RK [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Genet, D-91058 Erlangen, Germany
关键词
leukemia; MLL/ALL1/HRX; transcription; ENL; translocation; t(11; 19);
D O I
10.1038/sj.leu.2401534
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Translocations affecting the chromosomal locus 11q23 are hallmarks of infant leukemias. These events disrupt the MLL gene (also ALL-1 or HRX) and fuse the MLL amino terminus in frame with a variety of unrelated proteins. The ENL gene on 19p13.1 is a recurrent fusion partner of MLL. Whereas potential functions have been suggested for isolated domains of either MLL or ENL no experimental data exist for the biological properties of the complete chimeric MLL-ENL protein. We show here that the fusion of MLL with ENL creates a novel molecule that is a potent general transcriptional transactivator in transient reporter gene assays. MLL-ENL strongly transactivated several unrelated promoters including the promoter of Hoxa7 a potential target gene for the unaltered MLL protein. This transactivation capability was cell type specific and it was critically dependent on the contributions of the methyltransferase-homology (MT) region of MLL in combination with the C-terminus of ENL. Squelching experiments and gel retardation studies identified the ENL C-terminus as a binding partner for an unknown factor and the MLL MT region as a unique general DNA binding motif. The potential implications of these findings for the leukemogenesis by MLL-ENL are discussed.
引用
收藏
页码:1525 / 1533
页数:9
相关论文
共 50 条
  • [41] Purification of an MLL partner associated complex (MPAC) suggests a common role for MLL fusion partners in transcriptional elongation.
    Slany, Robert K.
    Mueller, Dorothee
    Bach, Christian
    Zeisig, Deniz
    Garcia-Cuellar, Maria-Paz
    Monroe, Sara
    Sreekumar, Arun
    Zhao, Ron
    Nesvizhskii, Alexey
    Chinnaiyan, Arul
    Hess, Jay L.
    BLOOD, 2006, 108 (11) : 231A - 231A
  • [42] ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+
    Garcia-Cuéllar, MP
    Schreiner, SA
    Birke, M
    Hamacher, M
    Fey, GH
    Slany, RK
    ONCOGENE, 2000, 19 (14) : 1744 - 1751
  • [43] ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+
    M P García-Cuéllar
    S A Schreiner
    M Birke
    M Hamacher
    G H Fey
    R K Slany
    Oncogene, 2000, 19 : 1744 - 1751
  • [44] Efficient and easy detection of MLL-AF4, MLL-AF9 and MLL-ENL fusion gene transcripts by multiplex real-time quantitative RT-PCR in TaqMan and LightCycler
    M W J C Jansen
    V H J van der Velden
    J J M van Dongen
    Leukemia, 2005, 19 : 2016 - 2018
  • [45] Efficient and easy detection of MLL-AF4, MLL-AF9 and MLL-ENL fusion gene transcripts by multiplex real-time quantitative RT-PCR in TaqMan and LightCycler
    Jansen, MWJC
    van der Velden, VHJ
    van Dongen, JJM
    LEUKEMIA, 2005, 19 (11) : 2016 - 2018
  • [46] The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures
    Benedikt, A.
    Baltruschat, S.
    Scholz, B.
    Bursen, A.
    Arrey, T. N.
    Meyer, B.
    Varagnolo, L.
    Mueller, A. M.
    Karas, M.
    Dingermann, T.
    Marschalek, R.
    LEUKEMIA, 2011, 25 (01) : 135 - 144
  • [47] Keeping RNA polymerase II on the run: Functions of MLL fusion partners in transcriptional regulation
    Basu, Subham
    Nandy, Arijit
    Biswas, Debabrata
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2020, 1863 (08):
  • [48] The leukemogenic AF4–MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures
    A Benedikt
    S Baltruschat
    B Scholz
    A Bursen
    T N Arrey
    B Meyer
    L Varagnolo
    A M Müller
    M Karas
    T Dingermann
    R Marschalek
    Leukemia, 2011, 25 : 135 - 144
  • [49] ENL-the MLL fusion partner in T(11;19), binds to the c-abl interactor protein 1 (AB11) that is fused to MLL in T(10;11).
    Cuellar, HPG
    Schreiner, S
    Birke, M
    Hamacher, H
    Slany, RK
    BLOOD, 1999, 94 (10) : 56A - 56A
  • [50] Quantification of virus-envelope-mediated cell fusion using a tetracycline transcriptional transactivator: fusion does not correlate with syncytium formation
    Ou, W
    Xiong, Y
    Silver, J
    VIROLOGY, 2004, 324 (02) : 263 - 272